The lowest effective plasma concentration of atomoxetine in pediatric patients with attention deficit/hyperactivity disorder: A non-randomized prospective interventional study

BACKGROUND: Atomoxetine (ATX) is used as a first-line, non-stimulant treatment for attention-deficit/hyperactivity disorder (ADHD), although no studies have systematically examined the relationship between plasma concentration and clinical efficacy. We conducted this non-randomized prospective inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimoto, Atsunori, Suzuki, Yutaro, Orime, Naoki, Hayashi, Taketsugu, Yoshinaga, Kiyohiro, Egawa, Jun, Ono, Shin, Sugai, Takuro, Inoue, Yoshimasa, Someya, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270591/
https://www.ncbi.nlm.nih.gov/pubmed/34232195
http://dx.doi.org/10.1097/MD.0000000000026552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270591/
https://www.ncbi.nlm.nih.gov/pubmed/34232195
http://dx.doi.org/10.1097/MD.0000000000026552

Ejemplares similares